We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDP
3026
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$220K ﹤0.01%
21,898
PBPB
3027
DELISTED
Potbelly
PBPB
$218K ﹤0.01%
51,613
PRVB
3028
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$217K ﹤0.01%
+14,553
New +$130K
BCEL
3029
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$213K ﹤0.01%
13,743
NATR icon
3030
Nature's Sunshine
NATR
$277M
$211K ﹤0.01%
23,543
RLH
3031
DELISTED
Red Lions Hotel Corporation
RLH
$211K ﹤0.01%
56,311
AC
3032
DELISTED
Associated Capital Group
AC
$210K ﹤0.01%
+5,364
New +$202K
LCUT icon
3033
Lifetime Brands
LCUT
$213M
$210K ﹤0.01%
30,133
LCTX icon
3034
Lineage Cell Therapeutics
LCTX
$286M
$208K ﹤0.01%
233,687
GAIA icon
3035
Gaia
GAIA
$48.1M
$207K ﹤0.01%
25,800
KLDO
3036
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$205K ﹤0.01%
40,815
+12,796
+46% +$81.3K
TYME
3037
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$203K ﹤0.01%
144,363
USWS
3038
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$201K ﹤0.01%
5,059
+57
+1% +$2.08K
MLP icon
3039
Maui Land & Pineapple Co
MLP
$320M
$198K ﹤0.01%
17,559
FTSI
3040
DELISTED
FTS International, Inc. Common Stock
FTSI
$197K ﹤0.01%
9,428
-1,149
-11% -$30.9K
CABA icon
3041
Cabaletta Bio
CABA
$457M
$195K ﹤0.01%
+13,898
New +$165K
VIR icon
3042
Vir Biotechnology
VIR
$1.5B
$195K ﹤0.01%
+15,466
New +$207K
KALA icon
3043
KALA BIO
KALA
$14.6M
$190K ﹤0.01%
21
SB icon
3044
Safe Bulkers
SB
$764M
$188K ﹤0.01%
110,082
BBCP icon
3045
Concrete Pumping Holdings
BBCP
$473M
$187K ﹤0.01%
34,136
MRKR icon
3046
Marker Therapeutics
MRKR
$19.2M
$187K ﹤0.01%
6,459
DZSI
3047
DELISTED
DZS Inc. Common Stock
DZSI
$187K ﹤0.01%
21,092
NL icon
3048
NLI Holdings
NL
$308M
$186K ﹤0.01%
47,504
+5,958
+14% +$24.4K
GCAP
3049
DELISTED
Gain Capital Holdings, Inc.
GCAP
$185K ﹤0.01%
46,648
LNAI
3050
Lunai Bioworks
LNAI
$10.7M
$184K ﹤0.01%
456
+265
+139% +$116K

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.